Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by St8Shoton Dec 09, 2017 8:21pm

46 Views

Post# 27125095

Looking for positive info

I'm looking for factual documents to read about the strength of NF and it's future and where it's headed. This board seems to be all over the place. Anybody want to offer specific editorials or Sedar fillings that they are favourable about? Not looking for "short" remarks. Not looking for oppressing remarks. Looking for substance, efficiently.

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages